The “FIND” Act, or Facilitating Innovative Nuclear Diagnostics Act, aims to improve access to advanced radiodiagnostic imaging for early diagnosis of heart disease, neurological disorders, and cancer to enhance patient
The landscape of nuclear medicine and molecular imaging is undergoing significant transformation due to recent changes in reimbursement policies by the Centers for Medicare & Medicaid Services (CMS). These changes
The “FIND” Act, or Facilitating Innovative Nuclear Diagnostics Act, aims to improve access to advanced radiodiagnostic imaging for early diagnosis of heart disease, neurological disorders, and cancer to enhance patient
The landscape of nuclear medicine and molecular imaging is undergoing significant transformation due to recent changes in reimbursement policies by the Centers for Medicare & Medicaid Services (CMS). These changes
“Supply Chain Logistics For A PET Radiotracer Manufacture”
Supply chain for an 18F radioisotope based PET radiotracer manufacture is discussed in detail along with brief manufacturing descriptions provided for context. A critical report for supply chain, manufacturing, business and investing personnel to familiarize with the basics of supply chain for this category of high application, commercially critical PET diagnostic imaging agents.
Click the icon below to download the eReport.
